SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Recent losses, debt and cash-flow concerns, and broader weakness in solar stocks are weighing on CSIQ. Bulls point to the U.S. manufacturing ramp, growing storage business and potential tax-credit benefits, while many traders speculate that heavy shorting is amplifying the decline.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Discussion centers on Ultragenyxs recent FDA approvals for its gene therapies and agreements to sell two priority review vouchers, adding non-dilutive funding and potential new product revenue. Bullish traders view the developments as strengthening the companys growth and profitability prospects, while skeptics are frustrated by the muted share-price response and want clearer evidence of launch execution and cost reductions.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Ciphers steep decline is being tied to its convertible-note financing and dilution concerns, alongside a broader selloff in AI data-center stocks as traders reassess debt, funding costs and the outlook for infrastructure spending. Bulls view the drop as an overreaction and point to long-term AI/HPC demand, while bears focus on financing risk and execution.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

A broad crypto-market selloff, led by Bitcoin weakness and liquidations, has kept XRP under pressure and prompted bearish talk alongside dip buying. Traders also debate whether Ripples banking, stablecoin, ETF and treasury developments will create demand for XRP itself, since many say the positive headlines have not translated into stronger price action.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is attracting attention for its strong run to new highs amid a rotation toward defensive healthcare stocks as technology shares weaken; traders are bullish on the momentum, while some warn of overextension and possible profit-taking. Separately, speculation that AbbVie could acquire Sellas Life Sciences appears in the discussion, but no deal is confirmed.

XYO is the cryptographic proof layer for the real world, collecting, validating, and delivering physical-world data to AI, robotics, Web3, and enterprise systems. XYO, the original Decentralized Physical Infrastructure Network (DePIN), has been operating since 2018 and now has more than 10 million nodes worldwide.   At the core of XYO is XYO Layer One, a scalable data blockchain built to support high-volume data industries such as AI, robotics, location intelligence, and real-world asset (RWA) systems. Designed for high throughput and low transaction costs, it gives these data-intensive applications the capacity to process and validate information across massive datasets. XYO Layer One anchors XYO's Proof of Location and Proof of Origin technologies, establishing a verified origin, precise timing, and trusted source behind every piece of data. This verified data directly feeds the XYO AI SDK, a product built by XYO to provide accessibility for developers to build AI-powered applications, autonomous agents, robotics integrations and more using real-world data.  XYO employs a unique dual-token model:  XYO Token: An externally traded token supporting the DePIN ecosystem, rewards, staking, and governance, enhancing overall ecosystem value and scarcity.   XL1 Token: Internal to the XYO Layer One blockchain, facilitating transactions, gas fees, and other blockchain-specific use cases.  The dual-token economics are strategically designed to increase scarcity and promote sustainable growth.   The XYO token has been available on major exchanges since 2018. Major exchanges include Coinbase and Revolut. The XL1 token is now also available.

XYO Network

XYO is drawing attention amid speculative calls for a rebound and anticipated announcements or partnerships, with some holders accumulating on dips and citing its AI and data-verification use cases. Skeptics counter that rallies repeatedly fade, pointing to weak volume and describing the swings as pump-and-dump behavior; no specific catalyst is confirmed in the discussion.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom CEO Hock Tans remarks comparing some AI investors to casino gamblers and warning that capital could constrain AI investment have fueled concern about the sustainability of data-center spending, amid a broader semiconductor selloff. Traders blame the comments for worsening sentiment, while others argue they were taken out of context and that strong AI demand remains intact.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Schwabs quarterly report is drawing attention: traders are weighing an earnings beat and record client inflows against a slight revenue miss, slower sequential growth, and weaker trading monetization. The mixed reaction has shares under pressure, with some investors emphasizing asset growth while others question the stocks near-term momentum.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Concern over the timing and valuation of Anthropics anticipated IPO is driving discussion, as traders speculate it could be delayed into 2027 and react to reports of a lower valuation than previously expected. Some see DXYZs discount to estimated NAV as an opportunity, while others question the NAV figures and worry that IPO delays could weigh on the fund.

ProShares Trust II - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is drawing attention as natural-gas futures swing on weather forecasts and weekly storage data, with traders focused on shoulder-season demand, ample production and the risk of a mild winter. Bulls point to tightening storage and possible cold-weather rallies, while bears expect continued pressure and note that BOILs leverage and futures-roll decay can magnify losses.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle

Key PointsAbbVie is the exact opposite of a high-yield trap...

SKYRIZI (risankizumab) and RINVOQ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

SKYRIZI (risankizumab) and RINVOQ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026 SKYRIZI (risankizumab) and RINVOQ (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel...

Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends

Key PointsAbbVie is a resilient Dividend King with a wide moat...

5 Stock Ideas for Your Short List

Forget the AI stocks. These five stocks have momentum right now.

Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?

Sanofi's upgraded 2026 outlook, Dupixent growth and attractive valuation give it an edge over AbbVie, despite pipeline setbacks and vaccine sales challenges.

Bet on These Healthcare ETFs to Benefit From the Aging US Population

With the US population aging rapidly, three healthcare ETFs offer exposure to companies developing treatments, drugs and medical devices for age-related conditions.

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know  

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

AbbVie's Subcutaneous Skyrizi Shows Endoscopic Benefits In Crohn's Diseases

(RTTNews) - Tuesday, AbbVie reported new Phase 3 AFFIRM data showcasing endoscopic outcomes with subcutaneous Skyrizi in adults with moderately to severely active Crohn's disease...

AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAbbVie is aggressively diversifying its pipeline to mitigate the revenue impact from its loss of patent exclusivity on Humira...

AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsAbbVie continues to diversify its portfolio through the successful expansion of newer therapies like Skyrizi and Rinvoq...

Biotech Deal Week: Lilly, Novo And Novartis Pay Up For Platforms, Not Pipelines

Equity

Bullish Sentiment

Track ABBV stock price, charts, news and real-time market activity on Stocktwits. Join the ABBV message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around AbbVie Inc stock.

ABBV Stock Price Today - Abbvie Inc News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$285.42
Prev Close	$283.40
Open	$283.61
Dividend Yield	2.91%
50-Day Moving Average	$262.45
Beta	0.28
Avg. Volume	4.13M
PE Ratio	80.70

52-Week High	$291.40
52-Week Low	$190.75
Market Capitalization	$504.37B
EPS (Annual)	$2.36
Price to Book	-84.98
Revenue Per Employee	$1.07M

Feed

News

Sentiment

Earnings

NewFutures

Fundamentals

Info

ABBV Fundamentals